v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Dilutive Common Stock Equivalents

The Company had the following potentially dilutive common stock equivalents:

 

   2026   2025 
   March 31, 
   2026   2025 
         
Options   1,319,394    1,319,394 
Restricted Stock Units   1,265,443    842,214 
Warrants   1,166,484    2,139,883 
Series B Preferred Stock   3,796,907    4,280,939 
Undeclared Cumulative Series B Preferred Stock Dividends   510,615    178,492 
Totals   8,058,843    8,760,922 
Schedule of Basic and Diluted Net Loss Per Share

The following table presents the calculation of the basic and diluted net loss per share and the effect of preferred stock dividends:

 

   2026   2025 
  

Three Months Ended

March 31,

 
   2026   2025 
Numerator:        
Net loss  $(1,761,432)  $(2,278,684)
Preferred stock dividends   (189,399)   (213,543)
Net loss available to common stockholders   (1,950,831)   (2,492,227)
Denominator:          
Weighted average shares of common stock outstanding - basic and diluted   10,948,121    7,463,578 
Basic and diluted net loss per share  $(0.18)  $(0.33)